Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C-Reference-Cited by-同舟云学术

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

Published:2011-02-11 Issue:3 Volume:53 Page:791-799
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Valenti Luca,Rumi MariaGrazia,Galmozzi Enrico,Aghemo Alessio,Del Menico Benedetta,De Nicola Stella,Dongiovanni Paola,Maggioni Marco,Fracanzani Anna Ludovica,Rametta Raffaela,Colombo Massimo,Fargion Silvia

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24123/fullpdf

Reference38 articles.

1. Prognosis of chronic hepatitis C: results of a large, prospective cohort study;Niederau;HEPATOLOGY,1998

2. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity;Adinolfi;HEPATOLOGY,2001

3. Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors;Akuta;J Hepatol,2002

4. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3;Rubbia-Brandt;J Hepatol,2000

5. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients;Westin;J Hepatol,2002

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of Art Update;Clinical Gastroenterology and Hepatology;2024-07

2. A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population;Cancer Medicine;2024-05

3. Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study;eClinicalMedicine;2024-01

4. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment;Journal of the Formosan Medical Association;2024-01

5. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression;Hepatology;2023-08-25